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Vitiligo is an acquired depigmentation disorder of the skin and hair caused by the selective destruction of
melanocytes from the epidermis that gives rise to well-defined depigmented patches. Strong genetic
predisposition has been well recognized. Previous reports have described five significant vitiligo susceptibility
loci spread over five different chromosomes, 1p31 (AIS1), 7q (AIS2), 8p (AIS3), 4q13–q21 (AIS4), and 17p (SLEV1).
In addition, our previous genome-wide scan of 106 Chinese vitiligo families presented suggestive linkages on
five additional chromosome segments, 1p36, 6p21–p22, 6q24–q25, 14q12–q13, and 22q12. To clarify the
significance of these suggestive loci, we have now extended this study to a total of 143 Chinese vitiligo
families and increased the marker density. Two linkage signals on 6p21–p22 and 22q12 that were previously only
suggestive now meet genome-wide criteria for significant linkage, establishing their importance as major
vitiligo susceptibility loci. Linkage signals on 1p36 and 6q24–q25 did not improve our previous findings, but on
14q showed negative in the 143 family cohorts. The results presented here further demonstrate the genetic
complexity of vitiligo pathogenesis and point to new chromosomal locations for further research to identify the
specific genes involved in this process.
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INTRODUCTION
Vitiligo (OMIM 193200) is the most common depigmentary
disorder resulting from the loss of functional melanocytes and
melanin from the skin and hair. It is estimated to affect
between 1% and 2% of the world population, although
within different ethnic groups studies have demonstrated an
incidence of 0.14–8.8% (Mosher et al., 1999).
Several theories have been put forward to explain the
pathogenesis of vitiligo, especially for the most prevailing
genetic hypothesis (Njoo and Westerhof, 2001). Strong
evidence from twin and family studies emphasizes the
importance of genetic factors in the development of vitiligo.
A positive family history for vitiligo has been reported to be
present in 6.25–38% of patients according to several
independent studies (Lerner, 1959; Bhatia et al., 1992;
Schallreuter et al., 1994; Kim et al., 1998; Alkhateeb et al.,
2003). In China, the prevalence of vitiligo in the patient’s
first-degree relatives is ninefold higher than in the general
population (Zhang et al., 2004a).
In the past 5 years, four genome-wide linkage analyses for
vitiligo susceptibility loci have been conducted. This has led
to the identification of 15 potential susceptible loci on 12
different chromosomes, such as significant ones on 1p31
(AIS1), 7q (AIS2), 8p (AIS3), and 17p (SLEV1) in the Caucasian
population and 4q13–q21 (AIS4) in Chinese families (Nath
et al., 2001; Alkhateeb et al., 2002; Spritz et al., 2004; Chen
et al., 2005). A number of candidate genes have been
suggested to mediate susceptibility to vitiligo, including
major histocompatibility complex, tumor necrosis factor-a,
catalase, ‘‘Forkhead box’’ D3, estrogen receptor 1, and
catechol-O-methyltransferase (Tursen et al., 2002; Jin et al.,
2004; Alkhateeb et al., 2005; Park et al., 2006; Yazici et al.,
2006). Variants in or around the NALP1 gene showed an
association with vitiligo alone, with an extended auto-
immune and autoinflammatory disease phenotype, or with
both (Jin et al., 2007). NALP1, which is located in the
susceptibility locus 17p, encodes NACHT leucine-rich repeat
protein 1, a regulator of the innate immune system.
Here we describe a follow-up linkage analysis with
more microsatellites and an additional 37 Chinese generali-
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zed vitiligo families, focusing on five suggestive susceptibility
loci we reported elsewhere, 1p36, 6p21–p22, 6q24–q25,
14q12–q13, and 22q12.
RESULTS
Detailed results of fine mapping are presented in Table 1.
Linkage signals on 22q12 (Figure 1) and 6p21–p22 (Figure 2)
have achieved significant linkage threshold. Our results do
not offer noticeable improvement of the linkage on
6q24–q25 and 1p36. However, there is no evidence for
the linkage of vitiligo to chromosome 14q, although vitiligo
has been reported to be suggestively linked to this region.
Identification of novel susceptibility loci at chromosomes
22q12 and 6p21–p22
Five novel markers flanking the original two microsatellites,
D22S280 and D22S283, were included to maximize the
information content, with average information of 79.3%. The
linkage results of the previous 106 families have improved
the multipoint nonparametric linkage (NPL) score from 1.75
(P¼0.039) to 3.49 (P¼0.0003) and the heterogeneity LOD
(HLOD) from 0.72 (a¼ 19%) to 2.28 (a¼35%), respectively.
Linkage evidence from 37 new families was supported by a
multipoint NPL score of 2.22 (P¼ 0.0078) and HLOD of 1.04
(a¼48.4%). The most significant multipoint linkage results of
the combined 143 families (NPL¼ 4.14, P¼ 0.000015;
HLOD¼3.26, a¼ 37.3%) occurred for the marker
D22S1163. Two-point nonparametric and parametric linkage
analyses also provided supporting evidence.
On 6p21–p22, we have genotyped the original 12 markers
with an interval distance of 1.9 cM in the 37 new families.
The most significant multipoint results of the combined 143
families occurred around D6S422 (NPL¼4.1, P¼0.000018;
HLOD¼3.73, a¼42.3%) and a second one around D6S273
(NPL¼ 3.22, P¼0.0005; HLOD¼2.47, a¼28.4). Two-point
analysis results also provided significant signals for two major
peaks at marker D6S422 (HLOD¼ 3.54, a¼ 49.4%) and
marker D6S273 (HLOD¼2.6, a¼ 33.1%).
Therefore, both nonparametric and parametric LOD scores
of the combined 143 families on 22q12 and 6p21–p22
surpassed the suggested genome-wide criteria for significant
linkage evidence (Po2.2 105) (Lander and Kruglyak, 1995).
Table 1. Summary of the multipoint LOD scores from the previous genome-wide scan and fine-mapping studies
Initial analysis1 Follow-up analysis2 Combined ANALYSIS3
Chromosome Interval NPL P HLOD a (%) NPL P-value HLOD a (%) NPL P HLOD a (%)
Genetic
model
22q124 D22S1167–D22S283 3.49 0.0003 2.28 35 2.22 0.0078 1.04 48.4 4.14 0.000015 3.26 37.3 Dom
6p21–p22 D6S289–D6S1629 3.16 0.00092 2.14 32 2.72 0.0015 2.48 82.1 4.10 0.000018 3.73 42.3 Dom
6q24–q25 D6S289–D6S291 2.98 0.0016 1.37 16 1.53 0.048 0.95 26.2 3.33 0.00038 1.95 17.1 Rec
1p36 D1S2828–D1S449 2.37 0.0093 1.17 11 1.1 0.115 0.0024 1.3 2.59 0.0042 0.78 10 Rec
14q12–q131 D14S283–D14S276 1.4 0.077 0.68 21.9 1.2 0.91 0 0 0.73 0.23 0.27 12.5 Dom
Dom, dominant inheritance; HOLD, heterogeneity LOD; NPL, nonparametric linkage; Rec, recessive inheritance.
To increase the marker intensity, we have added three and five new markers in the susceptible locus 14q12–q13 and 22q12, respectively, in this study.
The linkage signal in 14q12–q13 and 22q12, respectively, has been weaker and stronger than that we reported elsewhere for the same subsample of 106 families.
With the same markers in 1p36, 6p21–p22, and 6q24–25, the linkage signal of the subsample of 106 families is same as that reported elsewhere.
1Performed by analyzing various numbers of markers in 106 multiplex Chinese families.
2Performed by analyzing various numbers of markers in 37 multiplex Chinese families.
3Performed by analyzing various numbers of markers in 143 multiplex Chinese families.
4New markers were added to saturate the marker density in this study.
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Figure 1. Multipoint LOD scores on 22q12 from linkage analysis of 143
families.
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Figure 2. Multipoint LOD scores on 6p21–p22 from linkage analysis of
143 families. Red line, multipoint NPL scores; black line, multipoint HLOD
scores under a dominant model of inheritance; blue line, marker information
content.
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Suggestive linkage at chromosomes 6q24–q25 and 1p36
On chromosome 6q24–q25, we analyzed 11 original STR
markers between D6S262 (133.3 cM) and D6S1581
(170.1 cM). In all 143 families, analysis by GENEHUNTER
using information from all affected family members produced
evidence of linkage at genetic position 152.8 cM, with an
NPL score of 3.33 (P¼0.0004) and HLOD score of 1.95. The
multipoint analysis curve culminates here in a relatively
sharp peak. The joint linkage results of the combined 143
families provided more advanced signals than previous
results from 106 families.
Fine mapping of the 1p36 region, flanked by D1S2828
(50.1 cM) and D1S449 (60.9 cM), was performed with six
original STRs. We obtained a summary multipoint nonpara-
metric LOD score of 2.59 (P¼0.0042) at the 1.1 cM interval
D1S234–D1S2885. The recessive HLOD at this interval was
0.78, with a¼ 10%. These summary data still achieve
genome-wide criteria for suggestive linkage.
Negative results in regions with previously reported linkage
With respect to the suggested linkage signal on chromosome
14q, no suggestive indications of linkage were obtained with
either nonparametric or parametric analyses for four micro-
satellite markers flanking D14S70. A maximum NPL value of
0.73 (P¼0.23) was obtained at locus D14S70. A maximum
HLOD value of 0.27 (a¼ 12.5%) was obtained when a
dominant mode of inheritance was used at 1.5 cM proximal
to locus D14S70.
DISCUSSION
The pathogenesis of vitiligo is complex, with both genetic
and environmental factors probably contributing to the
development of the disease. Genes that contribute to vitiligo
susceptibility are still unknown. Studies in different popula-
tions have shown evidence for linkage on different chromo-
somes, implying an ethnic variation in the genetic
susceptibility to vitiligo. In this study, we made an extensive
analysis of our previous findings and provided significant
linkage evidence on 22q12 and 6p21–p22.
On the basis of criteria for significant linkage
(Po2.2105), significant evidence of linkage of vitiligo
to chromosome 22q12 was obtained in the region
D22S1167–D22S283, about 16 cM apart. The peak position
reached the highest NPL score of 4.14 (P¼ 0.000015)
at D22S1163 and was 17 cM away from the locus
D22S420–D22S539. Spritz et al. reported a maximum LOD
score (P¼ 1.06104) in 102 white families. Therefore, we
could conclude that the two loci on chromosome 22 are
independent and that the locus D22S1167–D22S283 was
more significant with respect to the linkage signals than
D22S420–D22S539. It is very interesting to pay more
attention to the two loci on chromosome 22, and covering
both loci for further association studies is important. Several
important candidate genes have been mapped to the
D22S1167–D22S283 region. X-box-binding protein 1, which
is located on chromosome 22q12, encodes a DNA-binding
protein targeting the HLA class II genes such as HLA-DR
and HLA-DP. Liou et al. (1991) found that X-box-binding
protein 1 acts as a transcription factor in B cells by recognizing
the X2 promoter elements of both human DR-a and human
DP-b. Deletion of X1, X2, and Y sequences eliminates the
expression of HLA class II genes in vitro and in transgenic
mice.
Evidence for another dominant vitiligo susceptibility
locus near D6S1584 on chromosome 6p21 is also a novel
finding in this study. Our linkage findings on 6p21–p22
are consistent with the suggested autoimmune pathogenesis
of vitiligo and the involvement of the major histocompat-
ibility complex locus in genetic predisposition to vitiligo.
Candidate gene-based genetic association analyses of vitiligo
in Chinese (Zhang et al., 2004b) and white populations
(Venneker et al., 1992; Zamani et al., 2001; de Vijlder et al.,
2004; Tastan et al., 2004; Fain et al., 2006) have revealed
multiple indications of association between alleles or
haplotypes of the major histocompatibility complex genes
and vitiligo. Therefore, our linkage finding on 6p21–p22
provides further linkage evidence for the involvement of the
major histocompatibility complex region in the genetic risk of
vitiligo.
Our results offer more suggestive evidence on chromo-
somes 1p36 and 6q24–q25. The linkage signal became
slightly stronger in 1p36, with the multipoint NPL score
arising from 2.37 to 2.59. However, the linkage curve
corresponds exactly with a previous report and the peak
position on chromosome 1p is yet at least 30 cM away from
AIS1 in the white population. Fine mapping with more
vitiligo families or stratification analysis would be next step
for this suggestive locus. Although the suggestive linkage
detected at 152.8 cM, with an NPL score of 3.33 on
chromosome 6q, needs to be replicated, some candidates,
such as estrogen receptor 1, make this region potentially
interesting (Jin et al., 2004).
We found no evidence for linkage of vitiligo to chromo-
some 14q, although vitiligo has been reported to be
suggestively linked to this region. Using linkage analysis,
scientists determine the likelihood that two loci (genetic
marker and disease gene) are linked by calculating the
logarithm of the odds or the LOD score, which is a ratio of
two likelihoods. To take into account multiple testing and
the likelihood of linkage before considering the genetic
evidence, a 5% chance of error occurs with an indication of
statistically significant linkage. Therefore, it is not difficult
to understand that the use of only one marker, D14S70,
might produce a false-positive result from our previous
reports.
In conclusion, this study has identified two novel
susceptibility loci of significant linkage on chromosomes 22
and 6, and replicated two areas of previous suggestive
linkage, but excluded the linkage to chromosome 14. Thus, it
reflects and supports the opinion that vitiligo is caused by
multiple genes, with presumed genetic heterogeneity and
with different combinations of predisposing genes segregating
in different families and populations. Association studies
using fine maps of replicated regions are now a major priority
to achieve the realistic goal of identifying genes influencing
variation in vitiligo.
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Table 2. Forty markers analyzed in this study
Combined analysis
Chromosome region Maker Het Size (bp) Position (cM) NPL P-value HLOD a (%)
1p36 D1S2828 0.87 247–279 50.092 0.82 0.2 0.2 6
D1S2734 0.84 108–134 53.151 1.4 0.08 0.53 10.7
D1S2674 0.8 216–260 54.583 1.57 0.05 0.8 13.9
D1S234 0.83 268–288 54.974 2.15 0.014 2.16 22
D1S2885 0.86 217–263 56.091 1.69 0.042 1.0 14.9
D1S449 0.74 221–245 60.92 1.46 0.068 0.6 11.7
6p21–p22 D6S289 0.79 163–185 33.631 2.91 0.0016 2.29 33.1
D6S1584 0.82 111–131 36.19 2.81 0.0022 2.84 42.4
D6S422 0.77 300–322 41.907 2.74 0.0028 3.54 49.4
D6S1660 0.77 203–217 45.752 1.92 0.025 0.72 23.2
D6S1691 0.86 213–251 46.45 2.65 0.0036 1.62 27.7
D6S276 0.83 205–237 46.737 1.98 0.022 1.4 25.6
D6S273 0.77 120–140 51.381 2.05 0.019 2.6 33.1
D6S1629 0.79 219–237 52.829 1.32 0.089 0.69 26.7
D6S1568 0.87 84–110 53.046 1.21 0.108 0.89 22.1
D6S1645 0.62 226–252 54.42 0.159 0.433 0.1 9.8
D6S291 0.72 198–210 55.127 0.64 0.255 0.02 0.04
D6S1602 0.61 194–208 56.495 1.0 0.153 1.84 45.2
6q24–q25 D6S262 0.82 167–183 133.328 1.54 0.059 0.51 10.3
D6S292 0.82 141–161 139.634 1.33 0.088 0.04 3.1
D6S308 0.75 193–203 145.482 1.44 0.07 0.46 11.3
D6S311 0.9 229–276 152.573 2.9 0.0017 1.42 16.1
D6S1687 0.66 115–141 156.134 1.47 0.067 0.82 17.1
D6S440 0.67 269–285 158.535 1.23 0.105 0.45 10.2
D6S290 0.7 253–263 159.944 1.59 0.053 0.9 15.9
D6S441 0.86 162–186 161.285 183 0.031 2.19 22.3
D6S448 0.72 169–183 163.414 0.91 0.177 0.54 9.7
D6S1577 0.86 146–168 163.985 1.2 0.11 0.33 7.7
D6S1581 0.72 215–229 170.925 0.77 0.22 0.012 1.8
14q12–q13 D14S2831 0.81 132–162 8.491 0.23 0.4 0.22 11.4
D14S2751 0.7 150–164 17.79 0.32 0.37 0.04 6.6
D14S70 0.75 103–119 31.508 117 0.16 0.65 21.3
D14S2761 0.76 241–253 50.702 0.9 0.82 0 0
22q12 D22S11671 0.74 266–278 32.026 1.92 0.026 1.6 40.1
D22S11631 0.76 147–163 36.256 3.05 0.001 2.78 40.2
D22S11501 0.68 213–235 39.336 2.53 0.005 1.74 30.1
D22S280 0.82 216–228 42.289 1.96 0.023 1.08 24.6
D22S12651 0.71 218–253 45.17 2.43 0.007 1.93 34.4
D22S283 0.89 132–160 47.905 1.86 0.029 1.23 23.4
D22S2721 0.69 132–150 53.928 1.58 0.054 0.87 19.9
Het, heterozygosity.
1New markers.
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MATERIALS AND METHODS
Family pedigrees and collection of clinical samples
We have now extended this study to a total of 143 Chinese multiplex
vitiligo families. Thirty-seven new families were ascertained as
described elsewhere (Chen et al., 2005). Approval to undertake this
study was granted by the Ethical Committee of the Chinese National
Human Genome Center at Shanghai. The study was conducted
according to the Declaration of Helsinki Principles. Informed
consent was obtained from each recruited subject. Consensus
diagnosis of vitiligo was assessed by two expert dermatologists
who carefully checked phenotypes by history, lesion maps, and, in
most cases, physical examination and/or photographs. The 143
family cohorts consisted of 369 affected (188 men and 181 women)
and 367 unaffected (155 men and 212 women) individuals, with a
mean age of onset of 18.6 years (range: 0–68). Among the additional
37 families, blood samples were collected from both parents in 25
families and from one parent in 12 families. The collection of blood
samples from the 106 families was as reported previously.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes by
standard procedures (Miller et al., 1988) and stored at 701C until
genotyped. Following the linkage analysis of 106 families in our
previous genome-wide scan, we observed suggestive linkage signals
with markers on 1p36, 6p21–p22, 6q24–q25, 14q12–q13, and
22q12. To saturate the marker density, an additional three and five
microsatellites in 14q13–q21 and 22q12, respectively, were
included in this study. A total of 40 microsatellites were analyzed
to confirm and further locate the linkage results (Table 2).
An interpolated genetic map that incorporates the information
from a physical map (build 36) and from published deCODE
and Marshfield genetic maps (see David Duffy’s QIMR home page)
was used to establish intermarker distances for the fine-mapping
study. The mean heterogeneity of these markers was 77%. All
the markers were genotyped in multiplex PCR, in accordance
with the manufacturer’s guidelines (Applied Biosystems, Foster City,
CA). Semiautomated fragment sizing was performed using
Genescan 3.0 software (Applied Biosystems) followed by allele
calling with GeneMapper 3.0 software (Applied Biosystems). Each
genotype was reviewed independently by two members of the
research team to confirm the accuracy of allele calling. The
programs PedCheck (O’Connell and Weeks, 1998) and MERLIN
(Abecasis et al., 2002) were used to identify any inconsistent
Mendelian inheritance or typing errors. Problematic genotypes were
assumed to have occurred in the genotyping process, and the
associated markers were set to ‘‘missing’’ for the corresponding
members.
Linkage analysis
Both multipoint nonparametric and parametric linkage analyses
were undertaken with GENEHUNTER version 2.1 (Kruglyak et al.,
1996). Parametric LOD analyses were performed under both
autosomal- and recessive-dominant inheritance models using the
affected-only-plus-founders approach, with 100% penetrance, 1%
phenocopies, and a disease allele frequency of 0.001, consistent
with the population prevalence of 0.19% in China (Xu et al., 2002).
We also performed two-point and multipoint ‘‘model-free’’ NPL
analyses using GENEHUNTER 2.0. NPL analysis is robust even when
the mode of inheritance is uncertain. As suggested by Lander and
Kruglyak (1995), Po3.0 107 was considered as highly significant,
Po2.2 105 as statistically significant, and P between 2.2 105
and 7.4 104 as suggestive evidence for linkage.
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